Physician profile
Joseph Mathews
NPI 1811123300
$167,709.23
in general payments reported to CMS, 2019-2025
62 companies · $5,260 in 2025
The $5,260 reported for 2025 was more than what 88% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112K · 2020: $19K · 2021: $13K · 2022: $7,623 · 2023: $7,250 · 2024: $4,285 · 2025: $5,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,653 · Food and Beverage: $7,131 · Travel and Lodging: $966 · Education: $45.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,652.50 |
| Food and Beverage | $7,130.90 |
| Travel and Lodging | $966.40 |
| Education | $45.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $52,256.36 | 2019-2025 | Korlym |
| Novo Nordisk INC | $22,096.00 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $21,599.42 | 2019-2025 | |
| Lilly USA, LLC | $18,849.21 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,591.98 | 2019-2024 | Synjardy, Tradjenta, Jardiance |
| Janssen Pharmaceuticals, INC | $7,821.13 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $7,643.56 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $5,970.40 | 2020-2025 | Recorlev, Gvoke Hypopen, Keveyis |
| Amgen INC. | $5,194.13 | 2019-2025 | Tepezza, Prolia, Evenity |
| Shire North American Group INC | $4,676.40 | 2019 | |
| Abbvie INC. | $2,362.99 | 2019-2025 | |
| Recordati_rare_diseases_inc. | $1,853.87 | 2021-2024 | Osilodrostat, Signifor Lar, Isturisa |
| Insulet Corporation | $1,512.15 | 2019-2025 | Omnipod |
| Abbott Laboratories | $1,068.42 | 2020-2025 | Freestyle Libre, Freestyle Libre 3, Absolute Pro |
| Horizon Therapeutics Plc | $438.66 | 2021-2023 | Tepezza |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $410.49 | 2019-2022 | |
| Medtronic, INC. | $331.02 | 2021-2025 | Minimed 780g, Intellis Adaptivestim |
| Astellas Pharma US INC | $329.46 | 2023-2025 | Veozah |
| Beta Bionics, INC. | $328.88 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Radius Health, INC. | $259.33 | 2019-2025 | |
| Ibsa Pharma INC. | $253.28 | 2019-2024 | Tirosint, Tirosint, Licart |
| Dexcom, INC. | $248.70 | 2019-2025 | Dexcom G6 Transmitter |
| Cequr Corporation | $221.80 | 2022-2025 | Cequr Simplicity |
| Antares Pharma, INC. | $155.46 | 2020-2023 | Tlando, Xyosted, Nocdurna |
| Tandem Diabetes Care, INC. | $153.97 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Endo Pharmaceuticals INC. | $147.46 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $142.58 | 2019-2022 | |
| Valeritas, INC. | $132.26 | 2019 | |
| Novartis Pharmaceuticals Corporation | $128.81 | 2022-2024 | |
| Ultragenyx Pharmaceutical INC. | $119.34 | 2019-2024 | Crysvita |
| Medtronic Minimed, INC. | $116.01 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $106.05 | 2020-2021 | |
| Ascensia Diabetes Care US INC. | $97.60 | 2023-2025 | |
| Amarin Pharma, INC. | $95.80 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $82.07 | 2021-2025 | Unithroid |
| Bayer Healthcare Pharmaceuticals INC. | $79.29 | 2021-2022 | |
| Opko Pharmaceuticals, LLC | $72.37 | 2019-2020 | |
| Renalytix Ai, INC. | $69.57 | 2022 | |
| Esperion Therapeutics, INC. | $55.61 | 2021-2023 | Nexletol |
| Neurocrine Biosciences, INC. | $47.54 | 2025 | |
| Zealand Pharma US, INC. | $45.65 | 2021-2022 | |
| Boston Scientific Corporation | $45.57 | 2022 | |
| Eusa Pharma (US) LLC | $43.97 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $40.75 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.76 | 2020-2021 | |
| Esteve Pharmaceuticals LLC | $34.94 | 2025 | Metopirone |
| Becton, Dickinson and Company | $34.38 | 2019 | |
| Clarus Therapeutics INC. | $30.25 | 2021 | |
| Aytu Biopharma, INC. | $27.52 | 2019 | |
| Vistapharm, INC. | $27.04 | 2021 | |
| Ascendis Pharma Endocrinology INC | $22.89 | 2023 | |
| Curonix LLC | $21.59 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Arkray USA, INC. | $21.09 | 2023 | |
| Lifescan, INC. | $20.08 | 2022 | |
| Alexion Pharmaceuticals, INC. | $19.81 | 2023 | Strensiq |
| Globus Medical, INC. | $19.78 | 2025 | Senza |
| Sun Pharmaceutical Industries INC. | $18.29 | 2020 | |
| Amryt Pharma Holdings Ltd | $17.84 | 2022 | |
| Madrigal Pharmaceuticals | $17.66 | 2025 | Rezdiffra |
| Acella Pharmaceuticals, LLC | $14.76 | 2024 | NP Thyroid 60 |
| Currax Pharmaceuticals LLC | $13.10 | 2021 | |
| Acerus Pharmaceuticals Corporation | $13.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mathews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.